Mirum Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Mirum Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Mirum Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$24.2M, a 0.17% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$108M, a 8.47% increase year-over-year.
  • Mirum Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$109M, a 16.8% increase from 2022.
  • Mirum Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$131M, a 24.3% increase from 2021.
  • Mirum Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$173M, a 66.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$109M +$22.1M +16.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$131M +$42.2M +24.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$173M -$69.1M -66.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 -$104M -$49.6M -90.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 -$54.7M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.